Francisco Javier Quintana PhD

Francisco J. Quintana, Ph.D. is a Professor of Neurology at the Ann Romney Center for Neurologic Diseases, at Brigham and Women’s Hospital, Harvard Medical School, and an Associate Member at the Broad Institute of Harvard and MIT. Dr. Quintana is also the incoming President of the International Society of NeuroImmunology (ISNI).

Dr. Quintana, a graduate of the University of Buenos Aires (1999, Argentina), obtained his Ph.D. in immunology at the Weizmann Institute of Science (2004, Israel). He received postdoctoral training at the Weizmann Institute of Science and Harvard Medical School. In 2009, Dr. Quintana joined the faculty of Harvard Medical School.

Dr. Quintana’s research investigates signaling pathways that control the immune response and neurodegeneration, with the ultimate goal of identifying novel therapeutic targets and biomarkers for immune-mediated disorders. Dr. Quintana has published over 150 peer-reviewed articles and book chapters. Dr. Quintana's work identified an important role for the transcription factor AHR in the control of inflammation-driven by adaptive and innate immune cells. His work has also identified important mechanisms that control neurodegeneration driven by CNS resident cells. In addition, Dr. Quintana’s research has resulted in multiple patents which have been the foundation of three companies: ImmunArray Ltd, Alma BioTherapeutics, and AnTolRx Inc.

Dr. Quintana is the recipient of the Lady Anne Chain Prize for Academic Excellence and Scientific Achievements, the Junior Investigator Award from the National Multiple Sclerosis Society, the Pathway to Independence Award of the National Institute of Allergy and Infectious Diseases, the Award for Outstanding Research Achievement form Nature Biotechnology, the Tecan Award for Innovation, the Harry Weaver Award from the National Multiple Sclerosis Society, the Mentor Award from Harvard Medical School, the Milestones in Multiple Sclerosis Research Award from the National Multiple Sclerosis Society, the American Association of Immunologists-BD Biosciences Investigator Award and the Barancik Prize of Innovation in Multiple Sclerosis Research.